Literature DB >> 14525902

Diabetes may be independent risk factor for hyperkalaemia.

Paul R Jarman, Hugh M Mather.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14525902      PMCID： PMC214139          DOI： 10.1136/bmj.327.7418.812

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases.

Authors:  Eike Wrenger; Regina Müller; Michael Moesenthin; Tobias Welte; Jürgen C Frölich; Klaus H Neumann
Journal:  BMJ       Date:  2003-07-19

2.  Life-threatening hyperkalaemia caused by angiotensin-converting enzyme-inhibitor and diuretics.

Authors:  M Odawara; M Asano; K Yamashita
Journal:  Diabet Med       Date:  1997-02       Impact factor: 4.359

3.  Hyperkalaemia in diabetes: prevalence and associations.

Authors:  P R Jarman; A M Kehely; H M Mather
Journal:  Postgrad Med J       Date:  1995-09       Impact factor: 2.401

4.  Hyperkalemia in the elderly.

Authors:  R N Walmsley; G H White; M Cain; P J McCarthy; J Booth
Journal:  Clin Chem       Date:  1984-08       Impact factor: 8.327
  4 in total
  7 in total

1.  Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial).

Authors:  Muthiah Vaduganathan; Alessandra Dei Cas; Robert J Mentz; Stephen J Greene; Sadiya Khan; Haris P Subacius; Ovidiu Chioncel; Aldo P Maggioni; Marvin A Konstam; Michele Senni; Gregg C Fonarow; Javed Butler; Mihai Gheorghiade
Journal:  Am J Cardiol       Date:  2014-06-24       Impact factor: 2.778

2.  Aldosterone antagonists in monotherapy are protective against streptozotocin-induced diabetic nephropathy in rats.

Authors:  Nora F Banki; Agota Ver; Laszlo J Wagner; Adam Vannay; Peter Degrell; Agnes Prokai; Renata Gellai; Lilla Lenart; Dorottya-Nagy Szakal; Eva Kenesei; Klara Rosta; Gyorgy Reusz; Attila J Szabo; Tivadar Tulassay; Chris Baylis; Andrea Fekete
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

3.  Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis.

Authors:  Yshai Yavin; Traci A Mansfield; Agata Ptaszynska; Kristina Johnsson; Shamik Parikh; Eva Johnsson
Journal:  Diabetes Ther       Date:  2016-01-12       Impact factor: 2.945

4.  Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease.

Authors:  Lauren B Cooper; Steven J Lippmann; Melissa A Greiner; Abhinav Sharma; Jacob P Kelly; Gregg C Fonarow; Clyde W Yancy; Paul A Heidenreich; Adrian F Hernandez
Journal:  J Am Heart Assoc       Date:  2017-12-23       Impact factor: 5.501

Review 5.  Mineral and Electrolyte Disorders With SGLT2i Therapy.

Authors:  Giuseppe Cianciolo; Antonio De Pascalis; Irene Capelli; Lorenzo Gasperoni; Luca Di Lullo; Antonio Bellasi; Gaetano La Manna
Journal:  JBMR Plus       Date:  2019-11-04

6.  Mineralocorticoid receptor antagonists for heart failure: a real-life observational study.

Authors:  Noemi Bruno; Gianfranco Sinagra; Stefania Paolillo; Alice Bonomi; Ugo Corrà; Massimo Piepoli; Fabrizio Veglia; Elisabetta Salvioni; Rocco Lagioia; Marco Metra; Giuseppe Limongelli; Gaia Cattadori; Angela B Scardovi; Valentina Carubelli; Domenico Scrutino; Roberto Badagliacca; Marco Guazzi; Rosa Raimondo; Piero Gentile; Damiano Magrì; Michele Correale; Gianfranco Parati; Federica Re; Mariantonietta Cicoira; Maria Frigerio; Maurizio Bussotti; Carlo Vignati; Fabrizio Oliva; Alessandro Mezzani; Giuseppe Vergaro; Andrea Di Lenarda; Claudio Passino; Susanna Sciomer; Giuseppe Pacileo; Roberto Ricci; Mauro Contini; Anna Apostolo; Pietro Palermo; Massimo Mapelli; Cosimo Carriere; Francesco Clemenza; Simone Binno; Romualdo Belardinelli; Carlo Lombardi; Pasquale Perrone Filardi; Michele Emdin; Piergiuseppe Agostoni
Journal:  ESC Heart Fail       Date:  2018-02-04

Review 7.  The Off-Target Effects, Electrolyte and Mineral Disorders of SGLT2i.

Authors:  Giuseppe Cianciolo; Antonio De De Pascalis; Lorenzo Gasperoni; Francesco Tondolo; Fulvia Zappulo; Irene Capelli; Maria Cappuccilli; Gaetano La La Manna
Journal:  Molecules       Date:  2020-06-15       Impact factor: 4.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.